NCT01919749View on ClinicalTrials.gov

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

October 31, 2016

Conditions
Metastatic Breast Cancer
Interventions
OTHER

treated recommended

Treatment will be recommended after reviewing the profiling analysis

Trial Locations (2)

22031

Virginia Cancer Specialists, Fairfax

85259-5499

Mayo Clinic, Scottsdale

All Listed Sponsors
collaborator

Side-Out Foundation

OTHER

lead

Translational Drug Development

OTHER

NCT01919749 - A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter